Journal article
Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture
International journal of infectious diseases, Vol.108, pp.112-115
07/2021
DOI: 10.1016/j.ijid.2021.05.027
PMCID: PMC8123529
PMID: 34004329
Abstract
•The de-isolation of immunocompromised COVID-19 patients is challenging.•A test-based rather than symptom-based approach is suggested.•The mean Ct value for negative viral cultures was 20.5 in this case series.•A test-based approach could lead to prolonged quarantine of non-infectious patients.•The de-isolation of immunocompromised patients needs disease-specific studies.
Immunocompromised patients with coronavirus disease 2019 (COVID-19) have prolonged infectious viral shedding for more than 20 days. A test-based approach is suggested for de-isolation of these patients.
The strategy was evaluated by comparing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (cycle threshold (Ct) values) and viral culture at the time of hospital discharge in a series of 13 COVID-19 patients: six immunocompetent and seven immunocompromised (five solid organ transplant patients, one lymphoma patient, and one hepatocellular carcinoma patient).
Three of the 13 (23%) patients had positive viral cultures: one patient with lymphoma (on day 16) and two immunocompetent patients (on day 7 and day 11). Eighty percent of the patients had negative viral cultures and had a mean Ct value of 20.5. None of the solid organ transplant recipients had positive viral cultures.
The mean Ct value for negative viral cultures was 20.5 in this case series of immunocompromised patients. Unlike those with hematological malignancies, none of the solid organ transplant patients had positive viral cultures. Adopting the test-based approach for all immunocompromised patients may lead to prolonged quarantine. Large-scale studies in disease-specific populations are needed to determine whether a test-based approach versus a symptom-based approach or a combination is applicable for the de-isolation of various immunocompromised patients.
Details
- Title: Subtitle
- Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture
- Creators
- Abeer N Alshukairi - Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi ArabiaAhmed M Tolah - Special Infectious Agents Unit-BSL3, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi ArabiaAshraf Dada - Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi ArabiaJaffar A Al-Tawfiq - Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi ArabiaReem S Almagharbi - Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi ArabiaMohammed F Saeedi - Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi ArabiaMohammed A Al-Hamzi - Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi ArabiaSherif A El-Kafrawy - Special Infectious Agents Unit-BSL3, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi ArabiaHusam A Bahaudden - Department of Medicine, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi ArabiaAiman El-Saed - Department of Infection Prevention and Control, King Abdulaziz Medical City, Riyadh, Saudi ArabiaMaha A Al-Mozaini - Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi ArabiaImran Khalid - Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi ArabiaLama K Hefni - Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi ArabiaAhmed M Hassan - Special Infectious Agents Unit-BSL3, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi ArabiaThamir A Alandijany - Special Infectious Agents Unit-BSL3, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi ArabiaLeena H Bajrai - Special Infectious Agents Unit-BSL3, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi ArabiaDaniyah T Bayumi - Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi ArabiaGhadeer E Albishi - Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi ArabiaSahar I Althawadi - Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi ArabiaNajla A Zabani - Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi ArabiaStanley Perlman - University of Iowa, Microbiology and ImmunologyEsam I Azhar - Special Infectious Agents Unit-BSL3, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
- Resource Type
- Journal article
- Publication Details
- International journal of infectious diseases, Vol.108, pp.112-115
- DOI
- 10.1016/j.ijid.2021.05.027
- PMID
- 34004329
- PMCID
- PMC8123529
- NLM abbreviation
- Int J Infect Dis
- ISSN
- 1201-9712
- eISSN
- 1878-3511
- Publisher
- Elsevier Ltd
- Language
- English
- Date published
- 07/2021
- Academic Unit
- Microbiology and Immunology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Infectious Disease (Pediatrics)
- Record Identifier
- 9984077787202771
Metrics
36 Record Views